Silo Pharma, Inc. (NASDAQ:SILO) Sees Significant Decline in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 191,600 shares, a drop of 39.2% from the September 15th total of 315,100 shares. Approximately 4.5% of the company’s stock are short sold. Based on an average daily volume of 5,010,000 shares, the short-interest ratio is currently 0.0 days.

Silo Pharma Trading Down 1.9 %

Shares of NASDAQ:SILO opened at $1.02 on Friday. Silo Pharma has a 12-month low of $0.84 and a 12-month high of $4.50. The business’s fifty day simple moving average is $1.21 and its 200-day simple moving average is $1.54.

Silo Pharma (NASDAQ:SILO) last announced its earnings results on Tuesday, August 13th. The company reported ($0.31) EPS for the quarter. The firm had revenue of $0.02 million during the quarter. Silo Pharma had a negative return on equity of 55.30% and a negative net margin of 4,881.57%.

Silo Pharma Company Profile

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.